Spectral AI, Inc.
NCM: MDAILive Quote
📈 ZcoreAI Score
Our AI model analyzes Spectral AI, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get MDAI Z-Score →About Spectral AI, Inc.
Healthcare
Medical Devices
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
📊 Fundamental Analysis
Spectral AI, Inc. demonstrates a profit margin of -38.5%, which is below the sector average, suggesting competitive pressure.
The company recently reported -46.3% revenue growth, which is negative, indicating a recent decline in revenue.
At a current price of $1.73, MDAI currently sits at the 29th percentile of its 52-week range (Range: $1.13 - $3.21).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Revenue Growth
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$55.06M
Trailing P/E
--
Forward P/E
-2.01
Beta (5Y)
0.91
52W High
$3.21
52W Low
$1.13
Avg Volume
691K
Day High
Day Low